글로벌 임상 시험 포장 및 라벨링 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 임상 시험 포장 및 라벨링 시장

임상 시험 포장 및 라벨링 시장은 2021년에서 2028년까지의 예측 기간 동안 약 7.00%의 시장 성장을 목격할 것으로 예상됩니다. Data Bridge Market Research의 임상 시험 포장 및 라벨링 시장 보고서는 예측 기간 내내 만연할 것으로 예상되는 다양한 요인에 대한 분석과 통찰력을 제공하고 시장 성장에 미치는 영향을 제공합니다. 임상 시험 의 세계화 와 규정의 조화는 임상 시험 포장 및 라벨링 시장의 성장을 가속화하고 있습니다.

임상 시험은 의료 전략, 치료 또는 기기가 인간에게 안전하고 효과적이며 유용한지 여부를 판단하는 데 도움이 되는 연구 조사를 말합니다. 이러한 연구는 특정 질병에 대한 의학적 접근 실험이 적절하다는 것을 발견합니다. 이러한 시험은 환자를 보호하고 신뢰할 수 있는 연구 결과를 생성하는 데 도움이 되는 엄격한 과학적 기준을 연구합니다. 이는 과학자 또는 연구자가 약물이든 의료 기기 이든 특정 질병에 대해 수행하는 약물 개발의 마지막 단계로 알려져 있습니다 .

The surge in the costs of drug discovery and the implementation of more stringent handling requirements for a type of biopharmaceutical products starting clinical trials are the major factors driving the clinical trial packaging and labelling market. The rise in pharmaceutical and biopharmaceutical research and development expenditures, growing number of clinical trials and increasing need for packaging and labelling for the products for the trials accelerate the clinical trial packaging and labelling market growth. The growing number of drug development activities and the use of this packaging for various testing services are required to check the quality and efficacy of the drug substance accelerate the clinical trial packaging and labelling market growth. Additionally, the increase in the research and development activities, rise in the investment for research projects, improving healthcare infrastructure and expansion of pharmaceutical and biopharmaceutical industries positively affect the clinical trial packaging and labelling market. Furthermore, innovations, growth in the biologics market and product launch extend profitable opportunities to the clinical trial packaging and labelling market players in the forecast period of 2021 to 2028.  

On the other hand, the rising cost of drug development and clinical trials are the factors expected to obstruct the clinical trial packaging and labelling market growth. The negative impact of COVID-19 is projected to challenge the clinical trial packaging and labelling market in the forecast period of 2021 to 2028.

This clinical trial packaging and labelling market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info on clinical trial packaging and labelling market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Clinical Trial Packaging and Labelling Market Scope and Market Size

The clinical trial packaging and labelling market is segmented on the basis of drug type, phase and therapeutic area. The growth amongst the different segments helps you in attaining the knowledge related to the different growth factors expected to be prevalent throughout the market and formulate different strategies to help identify core application areas and the difference in your target markets.    

• On the basis of drug type, the clinical trial packaging and labelling market is segmented into small-molecule drugs and biologic drugs.
• On the basis of phase, the clinical trial packaging and labelling market is segmented into phase I, phase II, phase III, phase IV and BA/BE studies.
• On the basis of therapeutic area, the clinical trial packaging and labelling market is segmented into oncology, neurological and mental disorders, infectious and immune system diseases, digestive system diseases, blood disorders and other therapeutic areas.

Global Clinical Trial Packaging and Labelling Market Country Level Analysis

The clinical trial packaging and labelling market is analyzed and market size, volume information is provided by country, drug type, phase and therapeutic area as referenced above.    

The countries covered in the global clinical trial packaging and labelling market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, Israel, Egypt, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.   

North America dominates the clinical trial packaging and labelling market during the forecast period of 2021 to 2028 because of the presence of well-established CROs and the high and growing investments in research and development by pharmaceutical and biopharmaceutical companies.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Clinical Trial Packaging and Labelling Market Share Analysis

임상 시험 포장 및 라벨링 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 위에 제공된 데이터 포인트는 임상 시험 포장 및 라벨링 시장과 관련된 회사의 초점에만 관련이 있습니다.

임상 시험 포장 및 라벨링 시장 보고서에서 다루는 주요 업체는 Sharp, PCI Pharma Services, MYODERM, Clinigen Group plc, KLIFO, CLINICAL SUPPLIES MANAGEMENT HOLDINGS, INC., Parexel International Corporation, Alium Medical Limited, Ancillare, LP, Movianto, Bionical Ltd., Thermo Fisher Scientific Inc., Catalent, Inc., Almac Group, Biocair, SIRO Clinpharm Private Limited 등 국내 및 글로벌 업체입니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-60114